Squarepoint’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $724K | Buy |
153,345
+75,295
| +96% | +$355K | ﹤0.01% | 1697 |
|
2025
Q1 | $358K | Buy |
78,050
+6,919
| +10% | +$31.8K | ﹤0.01% | 2098 |
|
2024
Q4 | $341K | Buy |
71,131
+46,293
| +186% | +$222K | ﹤0.01% | 2130 |
|
2024
Q3 | $116K | Sell |
24,838
-54,192
| -69% | -$254K | ﹤0.01% | 2309 |
|
2024
Q2 | $447K | Sell |
79,030
-156,573
| -66% | -$885K | ﹤0.01% | 1783 |
|
2024
Q1 | $968K | Sell |
235,603
-172,160
| -42% | -$708K | ﹤0.01% | 1376 |
|
2023
Q4 | $1.72M | Buy |
407,763
+315,672
| +343% | +$1.33M | ﹤0.01% | 1099 |
|
2023
Q3 | $398K | Buy |
92,091
+26,554
| +41% | +$115K | ﹤0.01% | 1755 |
|
2023
Q2 | $432K | Buy |
+65,537
| New | +$432K | ﹤0.01% | 1666 |
|
2023
Q1 | – | Sell |
-15,119
| Closed | -$112K | – | 2833 |
|
2022
Q4 | $112K | Buy |
+15,119
| New | +$112K | ﹤0.01% | 2041 |
|
2022
Q2 | – | Sell |
-10,076
| Closed | -$114K | – | 2668 |
|
2022
Q1 | $114K | Sell |
10,076
-78,117
| -89% | -$884K | ﹤0.01% | 2012 |
|
2021
Q4 | $1.38M | Buy |
88,193
+46,032
| +109% | +$722K | ﹤0.01% | 1057 |
|
2021
Q3 | $723K | Buy |
42,161
+11,295
| +37% | +$194K | ﹤0.01% | 1215 |
|
2021
Q2 | $664K | Buy |
30,866
+15,482
| +101% | +$333K | ﹤0.01% | 1437 |
|
2021
Q1 | $231K | Sell |
15,384
-12,398
| -45% | -$186K | ﹤0.01% | 2075 |
|
2020
Q4 | $365K | Buy |
+27,782
| New | +$365K | ﹤0.01% | 1722 |
|
2020
Q3 | – | Sell |
-75,724
| Closed | -$866K | – | 2703 |
|
2020
Q2 | $866K | Sell |
75,724
-5,346
| -7% | -$61.1K | 0.01% | 1013 |
|
2020
Q1 | $840K | Sell |
81,070
-36,159
| -31% | -$375K | 0.02% | 790 |
|
2019
Q4 | $1.92M | Sell |
117,229
-141,087
| -55% | -$2.32M | 0.01% | 910 |
|
2019
Q3 | $3.43M | Buy |
258,316
+175,213
| +211% | +$2.33M | 0.03% | 588 |
|
2019
Q2 | $1.17M | Sell |
83,103
-213,765
| -72% | -$3.01M | 0.01% | 1154 |
|
2019
Q1 | $5.46M | Buy |
296,868
+134,984
| +83% | +$2.48M | 0.06% | 410 |
|
2018
Q4 | $4.23M | Buy |
161,884
+54,269
| +50% | +$1.42M | 0.05% | 445 |
|
2018
Q3 | $2.47M | Buy |
107,615
+11,015
| +11% | +$253K | 0.03% | 637 |
|
2018
Q2 | $1.84M | Sell |
96,600
-1,227
| -1% | -$23.4K | 0.02% | 665 |
|
2018
Q1 | $1.65M | Buy |
97,827
+53,233
| +119% | +$897K | 0.03% | 631 |
|
2017
Q4 | $678K | Buy |
44,594
+947
| +2% | +$14.4K | 0.01% | 1006 |
|
2017
Q3 | $781K | Buy |
43,647
+30,047
| +221% | +$538K | 0.02% | 803 |
|
2017
Q2 | $222K | Sell |
13,600
-15,776
| -54% | -$258K | ﹤0.01% | 1262 |
|
2017
Q1 | $411K | Sell |
29,376
-7,824
| -21% | -$109K | 0.01% | 932 |
|
2016
Q4 | $593K | Buy |
+37,200
| New | +$593K | 0.02% | 735 |
|
2016
Q2 | – | Sell |
-25,600
| Closed | -$214K | – | 1364 |
|
2016
Q1 | $214K | Buy |
25,600
+1,300
| +5% | +$10.9K | 0.02% | 973 |
|
2015
Q4 | $226K | Buy |
+24,300
| New | +$226K | 0.02% | 927 |
|
2015
Q2 | – | Sell |
-13,800
| Closed | -$128K | – | 618 |
|
2015
Q1 | $128K | Buy |
+13,800
| New | +$128K | 0.04% | 392 |
|